Cell line · CVCL_5792
LX-2
Transformed cell line, Homo sapiens. 54 papers.
4 sourcescell-lines-2026-11-14-0.1.0
Download JSON
Cite this record
ConductScience Library. LX-2. Cell lines, record CVCL_5792. Release cell-lines-2026-11-14-0.1.0, 14 Nov 2026. https://conductscience.org/library/cell-lines/CVCL_5792
On this page
Cell line
As Cellosaurus gives it.
- Name
- LX-2
- Accession
- CVCL_5792
- RRID
- RRID:CVCL_5792
- Synonyms
- Lieming Xu-2
- Species
- Homo sapiens (Human)
- Sex
- Male
- Age at sampling
- Age unspecified
- Category
- Transformed cell line
- Derived from
- Liver (in situ)
- Cell type
- Hepatic stellate cell
- Parent
- LX-1 [Human HSC] (CVCL_5790)
- Entry created
- 2012-04-04
- Entry updated
- 2026-06-25
Source Cellosaurus
Problems0
Cellosaurus records no problem for this cell line.
None in this release.
Papers54
1 more article gives this line's RRID in its Methods without naming the line nearby, so it is not listed.
| Paper | Journal | Year | How we know | Retracted | Source |
|---|---|---|---|---|---|
| Comparative Metabolite Profiling of Betula pendula Roth and Betula pubescens Ehrh. Leaf Extracts Reveals Antioxidant and Hepatoprotective Potential. | Molecules | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Vitamin E treatment modulates steatotic and attenuates oxidative stress in a MASLD in vitro model. | Mol Biol Rep | 2026 | Its Methods give the RRID and name the line | PubMed | |
| S100 Calcium-Binding Protein 16 (S100A16) Promotes Hepatic Stellate Cell Activation Via Erb-B2 Receptor Tyrosine Kinase 2 (ERBB2)-mediated Glycolysis to Facilitate Liver Fibrosis. | Cell Biochem Funct | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Development of a matrix-supported 2.5-dimensional co-culture model: an in vitro platform for studying liver cell interaction and disease mechanisms. | RSC Adv | 2026 | Its Methods give the RRID and name the line | PubMed | |
| A trifluoromethyl quinazoline inhibits hepatocellular carcinoma proliferation through HDAC1 binding and multi-target mechanisms. | iScience | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Targeting p21-High Senescent Kupffer Cells Nanotherapeutically Potentiates Antitumor Immunity in Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombus. | Adv Sci (Weinh) | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Serum SOS1 as a prognostic biomarker and therapeutic target for progressive liver disease. | iScience | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Pancreatic Cancer-Derived Small Extracellular Vesicles Remodel Hepatic Pre-Metastatic Niche via Hybrid Epithelial-Mesenchymal States. | Int J Mol Sci | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Sex Hormone-Binding Globulin Prevents Carbon Tetrachloride-Induced Liver Fibrosis Development. | Int J Mol Sci | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Curcumin Targets Crispld2 to Suppress Hepatic Stellate Cell Activation via PI3K/AKT Pathway Inhibition in Hepatic Fibrosis. | Liver Int | 2026 | Its Methods give the RRID and name the line | PubMed |
1 to 10 of 54
See all 54 papersRelatives6
| Relation | Cell line | Accession | Problem | Source |
|---|---|---|---|---|
| Parent | LX-1 [Human HSC] | CVCL_5790 | Cell lines | |
| Derived from it | EDITGENE LX-2-FLUC | CVCL_F5TJ | Cell lines | |
| Derived from it | EDITGENE PDPN Overexpression LX-2 Stable Cell Line | CVCL_F6F8 | Cell lines | |
| Derived from it | HyCyte LX-2 KO-hNGLY1 | CVCL_E1LU | Cell lines | |
| Derived from it | HyCyte LX-2 KO-hTPP1 | CVCL_F1RF | Cell lines | |
| Derived from it | HyCyte LX-2-Luc | CVCL_E3HV | Cell lines |
Cell banks4
Data dates
The date of each source this release read.
Sources 4
- CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
- PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
- NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
- PubMedNLM's terms
Each source's terms
- CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
- PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
- NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
- PubMedNLM's terms
Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.
For software
Read this cell line from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/cell-lines/v1/CVCL_5792
GET https://conductscience.org/api/cell-lines/v1/CVCL_5792/papers?page=2